The TXNL4A gene helps your cells process RNA, the working copy made from DNA, so proteins can be built correctly. When this gene does not work well, cells may handle these instructions poorly, which can disrupt early development. Pathogenic variants in the TXNL4A gene are linked to Burn-McKeown syndrome, a rare condition that can affect the face, airways, ears, hearing, and sometimes the heart. Effects can vary from person to person.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or guide processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they are turned on. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
TXNL4AGene function
What if the gene works
The TXNL4A gene helps cells edit RNA messages before they are used to make proteins. This supports normal growth, development, and day to day cell function.
Risk
What if the gene does not work
Changes in the TXNL4A gene can cause Burn-McKeown syndrome, which often affects facial development, hearing, and the airway, and may include cleft lip or palate. Milder and more severe variants can influence which features appear and how marked they are.
Treatment
What does that mean for your treatment
No TXNL4A-specific treatment or drug-selection approach is currently established.
Conditions associated with TXNL4A
Gene function
What if the gene works
Every day, your cells make RNA copies of genes before they build proteins. These RNA messages need careful editing, and the TXNL4A gene helps guide that step. When it is working normally, cells can prepare many messages in a steady, orderly way.
The TXNL4A gene helps cells trim and join RNA messages after genes are copied. This editing step removes noncoding sections and keeps the final instructions ready for protein production.
Its protein is part of the spliceosome, the cell's RNA editing machinery. It helps this complex stay organized so many RNA messages can be processed accurately.
Because RNA splicing shapes which instructions are kept, the TXNL4A gene supports normal gene activity across many tissues. This is a central part of what the TXNL4A gene does in the body.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TXNL4A gene can lower how much working protein a cell makes or make the protein less stable, which disrupts RNA splicing (the cell’s editing step for gene messages). This is how TXNL4A gene variants affect splicing: milder changes may only partly reduce activity, while more severe variants can cause a larger drop and more widespread processing errors. In Burn-McKeown syndrome, stronger loss of TXNL4A function is often linked to earlier or more pronounced features.
How variants are linked to conditions
Variants in the TXNL4A gene cause Burn-McKeown syndrome, a rare inherited condition associated with facial differences, hearing loss, cleft lip or palate, and blocked or narrow nasal passages. The best-established finding is a link between TXNL4A gene variants and Burn-McKeown syndrome, usually when disease-causing variants are present in both copies of the gene. This result can confirm the diagnosis in the right clinical setting.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and simply represent natural variation among people. In many genes, carrying a variant tied to a condition signals a possible association, not a definite diagnosis, especially when more than one gene and environmental influences contribute. In certain situations, though, a single well-characterized variant in a specific gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TXNL4A, risk is mainly related to the gene changes inherited from your parents rather than lifestyle or everyday exposures. There is not yet broadly confirmed evidence that diet, exercise, or other outside factors clearly increase or reduce risk linked to TXNL4A.
Inheritance of TXNL4A variants
TXNL4A-related conditions are inherited in an autosomal recessive pattern. For families asking how TXNL4A gene variants are inherited, this usually means a person inherits one altered copy of the TXNL4A gene from each parent. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. Because the TXNL4A gene is on an autosome, this pattern is the same for boys and girls.
What does my TXNL4A result mean for my family?
TXNL4A changes linked to Burn-McKeown syndrome usually affect families in a recessive pattern, which means parents are often healthy carriers. Brothers and sisters of someone with a disease-causing TXNL4A result may also be affected or be carriers, and other relatives may carry the same change without knowing it. Family members may want to talk with a genetics professional about what this result could mean for them.
Genetic information
Genetic testing
How you find out about variants
TXNL4A genetic testing usually analyzes DNA from a blood or saliva sample using sequencing, sometimes with added checks for missing pieces of the gene. This testing for TXNL4A variants may find a disease-causing variant, no relevant change, or a variant of uncertain significance (a change whose effect is not yet clear).
When should I consider getting a genetic test?
Testing for the TXNL4A gene may be worth considering when a child has features linked to Burn-McKeown syndrome, such as unusual facial development, hearing loss, cleft lip or palate, or blocked nasal passages. It can also help when this condition is known in the family or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you varies depending on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds at the drug’s target, so the same treatment may work better for one person than another. This is common and can influence both how well a medicine works and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. To explore this subject in greater detail, you can find more in the LearnHub.
Drugs influenced by the TXNL4A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work. Questions about side effects, trouble starting a new medicine, or concerns about whether a treatment is right for you are best discussed with your doctor or pharmacist.
History
Burn-McKeown syndrome was first recognized from a pattern of facial and airway features seen in a small number of families, years before its genetic cause was clear. Initially understood only through visible traits, later recognized as tied to a specific gene, the TXNL4A gene became linked to the condition after modern DNA studies identified changes affecting both copies of the gene. This was an important step because it connected a rare clinical picture to a shared inherited cause. From these first observations, research expanded steadily. Scientists then clarified that some affected people carry a mix of variants, including changes in the gene itself and in nearby control regions that reduce how much of the gene is made.